World Clinical Biomarkers & Companion Diagnostics Summit

September 22-25, 2025

Join Akoya Biosciences at the World Clinical Biomarkers & Companion Diagnostics (CDx) Summit.

 

📍 Westin Seaport
      425 Summer Street, Boston, MA 02210, United States

 

Attend our talk at the conference on Thursday, September 25, 2025, @ 11:50 a.m. ET

Advancing Multiplex Immunofluorescence: Akoya Biosciences is Pioneering Multiplex Immunofluorescence (mIF) Companion Diagnostic Development to Drive Key Clinical Decision Making

  • Akoya Biosciences’ multiplex immunofluorescence technology enables high-plex, diagnostic biomarker analysis built upon the PhenoImager HT imaging instrument.
  • CDx system development requires stringent controls and QC procedures to support multisite deployment capabilities and ensure patient safety.
  • Akoya Biosciences is a capable diagnostic development partner with multiple late-stage clinical trials and CDx development programs—accelerating spatial diagnostic adoption in precision oncology.

 

Presenter

Mark Venghaus
Senior Director of CDx, Akoya Biosciences

Schedule a meeting with the team

Hold down "ctrl" to select multiple options.

By registering on this web page, you are consenting and agreeing to the collection and use of your information by Akoya Biosciences in accordance with its Privacy Policy.